Industry 4.0 has brought lot of change in many sectors like transportation and logistics, manufacturing, aviation, and oil and gas production. New waive that is coming up is Pharma 4.0 i.e. Implementation of Industry 4.0 in pharmaceuticals
Understanding Pharma 4.0
Similar to Industry 4.0, Pharma 4.0 refers inter-connectivity, automation, integration of AI and ML to make it possible to gather and analyze data across machines, enabling faster, more flexible, and more efficient processes to produce higher-quality goods at reduced costs.
Why to move towards pharma 4.0
Remaining competitive, ensuring to keep market place in tact is pushing pharma manufacturers to improve productivity ensure better control on monitoring. harma 4.0 technology allows for continuous, real-time monitoring of manufacturing processes so any drift away from specified parameters can be predicted and rectified before it turns into a deviation, avoiding the associated down time and loss of product.
Wining over existing control strategies
Pharma industry always had automated process control right from beginning of 90s. But this relatively old system which only alerts when already damage is done. Pharma 4.0 on other hand is proactive in nature. By using sensors and using continuous monitoring techniques, integrated with AI and analytics provides predictive analysis and a world of other business insights that are currently unavailable because they’re buried in unstructured, dispersed, incomplete data.
Role of Big Data
Big data analytics draws data from sources that have traditionally been disconnected from one another, and looks for relationships and trends that were previously undetectable. For example, data from the online inspection system described above can be combined with that from equipment maintenance and engineering systems to streamline maintenance schedules; combining production data with that from sales and dispatch systems can streamline production planning.
How will this transform to a waive
Although pharma is very precautious industry, which requires tighter control and is coupled with very strong statutory norms. However, still Governments, regulators are taking every possible step help enterprises to move towards Pharma 4.0 soon Pharma 4.0 is be waive in itself
Crafsol with its leaders, who have strong understanding of pharmaceutical industry, is ready and keen to help companies to start Pharma 4.0, get in touch with our team now.
